Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GHSI

Guardion Health Sciences (GHSI) Stock Price, News & Analysis

Guardion Health Sciences logo

About Guardion Health Sciences Stock (NASDAQ:GHSI)

Key Stats

Today's Range
$3.22
$3.22
50-Day Range
$3.22
$3.50
52-Week Range
$3.04
$18.00
Volume
N/A
Average Volume
105,261 shs
Market Capitalization
$4.35 million
P/E Ratio
0.66
Dividend Yield
155.28%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Receive GHSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GHSI Stock News Headlines

The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel
Guardion Health Sciences Inc (GHSI)
See More Headlines

GHSI Stock Analysis - Frequently Asked Questions

Guardion Health Sciences, Inc. (NASDAQ:GHSI) released its quarterly earnings data on Monday, August, 12th. The company reported ($42.00) earnings per share (EPS) for the quarter. The firm earned $0.26 million during the quarter. Guardion Health Sciences had a net margin of 22.79% and a negative trailing twelve-month return on equity of 73.69%.

Guardion Health Sciences's stock reverse split before market open on Sunday, January 8th 2023.The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Guardion Health Sciences (GHSI) raised $4 million in an initial public offering on Friday, April 5th 2019. The company issued 1,250,000 shares at a price of $3.00-$4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Guardion Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), GE Aerospace (GE).

Company Calendar

Last Earnings
8/12/2019
Today
8/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:GHSI
CIK
1642375
Employees
10
Year Founded
2009

Profitability

EPS (Trailing Twelve Months)
$4.87
Trailing P/E Ratio
0.66
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$160 thousand
Net Margins
22.79%
Pretax Margin
-20.29%
Return on Equity
-73.69%
Return on Assets
-48.17%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
16.68
Quick Ratio
16.59

Sales & Book Value

Annual Sales
$12.25 million
Price / Sales
0.35
Cash Flow
$0.14 per share
Price / Cash Flow
23.15
Book Value
$6.39 per share
Price / Book
0.50

Miscellaneous

Outstanding Shares
1,350,000
Free Float
1,332,000
Market Cap
$4.35 million
Optionable
Not Optionable
Beta
0.73

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:GHSI) was last updated on 8/18/2026 by MarketBeat.com Staff.
From Our Partners